Tregoning Kathleen
SEC insider (Form 3/4/5 filer). CIK 0001830764. Officer at Kailera Therapeutics, Inc. (KLRA) and 2 other issuers. 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 6, 2026. Located in WALTHAM, MA.
Companies Tregoning Kathleen has filed insider reports for
- Kailera Therapeutics, Inc. (KLRA): Officer, See Remarks
- Spero Therapeutics, Inc. (SPRO): Director
- COMPASS Pathways plc (CMPS): Director
Tregoning Kathleen
CIK: 0001830764
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 6, 2026KLRA
Kailera Therapeutics, Inc.
AwardDirectStock Option (right to buy)
175K shares- - Jun 23, 2026SPRO
Spero Therapeutics, Inc.
AwardDirect10K shares- - May 27, 2026CMPS
COMPASS Pathways plc
AwardDirectShare Option (Right to Buy)
41.1K shares- - Jun 12, 2025SPRO
Spero Therapeutics, Inc.
AwardDirect20K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 6, 2026 |  KLRA Kailera Therapeutics, Inc. | Award Stock Option (right to buy) | 175,000 | - | - | Direct |
| Jun 23, 2026 |  SPRO Spero Therapeutics, Inc. | Award | 10,000 | - | $0 | Direct |
| May 27, 2026 |  CMPS COMPASS Pathways plc | Award Share Option (Right to Buy) | 41,119 | - | - | Direct |
| Jun 12, 2025 | SPRO Spero Therapeutics, Inc. | Award | 20,000 | - | - | Direct |
1-4 of 4 transactions